COMMUNIQUÉS West-GlobeNewswire

-
RedHill Biopharma Announces Positive Top-Line Results from Phase III Study of RHB-104 in Crohn’s Disease
30/07/2018 -
resTORbio to Present at the Canaccord Genuity 38th Annual Growth Conference
30/07/2018 -
Xeris Pharmaceuticals Announces New Board Members and New Executive to Management Team
30/07/2018 -
Genetic Technologies Announces Appointment of Swisstec as Non-Exclusive Asian Distributor
30/07/2018 -
Opthea Doses First Patient in Phase 2a Trial for OPT-302 in Diabetic Macular Edema
30/07/2018 -
The Ensign Group Schedules Second Quarter 2018 Earnings Call for Friday, August 3, 2018
30/07/2018 -
Arrayit Corporation Signs Allergy Testing Contracts with a Nationwide Consortium of Medical Clinics
30/07/2018 -
Kymab Announces Promising Results from Initial Clinical Study of New Antibody KY1005 for Treatment of Autoimmune Diseases
30/07/2018 -
New STING study opens up multi-billion dollar cancer immunotherapy market for LIDDS unique NanoZolid® technology
30/07/2018 -
Daiichi Sankyo Enters Worldwide Licensing Agreement with Glycotope for Gatipotuzumab Antibody Drug Conjugate
30/07/2018 -
Herantis Pharma Oyj: Manager's Transactions - Pekka Simula
30/07/2018 -
Changes to Biohit Oyj’s management
30/07/2018 -
CrownBio étend de nouveaux modèles humanisés destinés au développement d’immunothérapies ciblées à son centre de recherche de San Diego, en Californie
30/07/2018 -
Shire plc : Miscellaneous
30/07/2018 -
MediciNova Announces Full Enrollment in ALS Biomarker Clinical Trial
30/07/2018 -
Chembio Diagnostics Announces Collaboration with FIND to Develop Hepatitis C Virus Point-of-Care Diagnostic Test
28/07/2018 -
Veritas Pharma Announces Loan to Marapharm and Cancellation of Stock Options
28/07/2018 -
Kalytera Therapeutics Announces Adjournment of 2018 Annual and Special Meeting
27/07/2018 -
CLS Holdings USA Appoints Frank Tarantino, CPA as Chief Financial Officer
27/07/2018
Pages